The Chemours Company (CC) Cash Flow Statement
The Chemours Company (CC) generated $397.0M of operating cash flow over the twelve months to 2026-06-30, spent $179.0M on capital expenditure and had free cash flow of $218.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CCThe Chemours CompanyFollow CC — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 17 Feb, in 116 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.18 | 0.59 | 0.64 | 1.14 | 0.65 | 0.81 | 0.81 | 0.76 | 0.56 | -0.63 | 0.26 | 0.40 | |
| Capital expenditure | 0.52 | 0.34 | 0.41 | 0.50 | 0.48 | 0.27 | 0.28 | 0.31 | 0.37 | 0.36 | 0.21 | -0.18 | |
| Free cash flow | -0.34 | 0.26 | 0.23 | 0.64 | 0.17 | 0.54 | 0.54 | 0.45 | 0.19 | -0.99 | 0.05 | 0.22 | |
| Dividends paid | 0.11 | 0.02 | 0.02 | 0.15 | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.15 | 0.08 | — | |
| Share repurchases | — | — | 0.11 | 0.64 | 0.32 | 0.00 | 0.17 | 0.50 | 0.07 | — | — | — | |
| Stock-based compensation | — | — | — | — | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | — |
USD billions · SEC XBRL
The Chemours Company — questions
- What is The Chemours Company's operating cash flow?
- $397.0M over the twelve months to 2026-06-30.
- How much does The Chemours Company spend on capital expenditure?
- $179.0M over the twelve months to 2026-06-30.
- What is The Chemours Company's free cash flow?
- $218.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from The Chemours Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.